Professor-Incharge NDDTC Laboratories, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences, New Delhi, India  

1. Name: Dr. Raka Jain
2. Career Positions: All India Institute of Medical Sciences (AIIMS), National Drug Dependence Treatment Centre (NDDTC), Assistant Professor (1988-1992); Associate Professor (1992-1996); Additional Professor (1996-2005); Professor (2005-to date) Current Job: Professor – Incharge NDDTC Laboratories (Drug Abuse Testing Laboratory, Biochemistry and Preclinical Psychopharmacology (Behavior) Laboratory), Teaching and Research.
3. Email address: This email address is being protected from spambots. You need JavaScript enabled to view it. ,Tel No. 91-11-26593595 (W), Mobile: 8130884449, Fax: 091-11-26588663.

4. 4. Qualifications: MSc. (Chemistry, 1978), Ph.D. Medicinal (Chemistry, 1983) , CChem FRSC (U.K, 2000).

6.    Field of interest: Drug Addiction

1. Drug Analysis (Toxicology)
2. Newer Psychoactive Drugs
3. Neuro-Psychopharmacology (Biochemical, Molecular and preclinical Behavioral studies)
4. Abuse liability studies of psychotropic drugs
5. Validity of drug use reporting and pattern of drug abuse among drug users
6. Tobacco cessation

7.      Other Research and Professional Experience:  

            Planned and Established the Drug Abuse Testing Laboratory at De-Addiction Centre of All India Institute of Medical Sciences, New Delhi, India.   This is the first time such a laboratory has been established in the   

             country. The laboratory started functioning in June 1989.  

            Standardized methodologies for screening and confirmation of drugs of abuse in biological fluids and established quality control of the laboratory.  

            Expertise in handling operation and interpretation of results via sophisticated techniques like LC-QTOF-MS, GC-MS, HPLC, GLC, TLC, MS, ELISA, Biochemistry Autoanalyser etc.  

            Planning in setting up of Drug abuse Screening laboratories for other designated De-Addiction Centres of the country.  

            Officer- Incharge of Drug Abuse Testing laboratory at the National Drug Dependence Treatment Centre, AIIMS since 1988 Drug Tests in body fluid

            ix)      Delivered an Invited talk on "Role of Laboratory Services in Drug Dependence Treatment Programme" on Forensic Science day, Amity University Noida (23rd March 2012).  

            x)       An Overview of Drug Abuse Testing and its Relevance to Clinical Practice" (invited talk). Jain, R. In: Global Initiative of Academic Networks (GIAN) Workshop, on “Neuropharmacology of Addiction”                           at  Panjab University, Chandigarh, October 09-13, 2017, Ministry of Human Resource Development ( MHRD) Govt. of India.  

            xi)       Delivered an Invited lecture entitled “New psychoactive substances and their detection” (Jain R. ). In Virtual workshop on 'Next-Generation Forensics' conducted by the Department of Life Sciences,                            University of Calicut, Kerala, India in collaboration with the Kerala Police Academy (Virtual online, 25th Jan. 2021).

8.    Thesis supervised as MD/DM/PhD  

a.     Chief Guide for Postgraduate Medical Students M.D. Thesis –  Sixteen (Completed)

i)      Abuse Liability of Diazepam through Different Routes of Administration (1996-1998).

ii)      Assessment   of  Differential   Dose   of  Buprenorphine   for  Long   Term Pharmacotherapy of Opioid Dependent Subjects ( 1998-2001).  

iii)     Pattern and Extent of Benzodiazepine Use among Alcohol and Opioid Dependent Subjects (2001-2003).  

iv)     Assessment of Abuse liability of Pheniramine     among human subjects (2003-2005)  

v)     Acute Effects of Sustained Release Morphine as Against Buprenorphine in Opioid Dependent Patients ( 2004- 2006).  

vi)    Comparative Evaluation of Memantine with Buprenorphine in Suppression of Naloxone precipitated acute withdrawal in opioid-dependent subjects (2004- 2006).  

vii)    Effect of Naltrexone and Buprenorphine on Smoking in Opioid Dependent Subjects (2005-2008).  

viii)   Tobacco Use in Opioid Dependent Subjects on Agonist Maintenance Treatment (2008- 2010).  

ix)    Clinical assessment and biochemical Validation of Adolescent Inhalant Users in Treatment Setting (2009-2011).  

x)    Assessment of Abuse liability of Tramadol in Opioid Dependent Subjects (2010-2012).  

xi)   Assessment of effect of sweet tastants on cue-related craving among recently detoxified alcohol-dependent subjects (2012-2015).

xii)   Effectiveness of Screening and Brief Intervention For Moderate/High-Risk Alcohol Use Among Patients On Buprenorphine Maintenance: A Clinical and Alcohol-Biomarker Study (2013 –2016).  

xiii)  Platelets Monoamine Oxidase B activity levels and Cognitive functions in patients with alcohol Dependence: An exploratory study (2014-2017).  

xiv)  A study of Serum Brain-Derived Neurotrophic Factor levels in patients with alcohol dependence during withdrawal (2015-2018).  

xv) A comparative study of serum BDNF levels in patients with alcohol dependence, depression and co-morbid alcohol dependence and depression (2017-2020).  

xvi) Assessment of Stress Biomarkers in Opioid Dependent Youth and its association with stress and coping: An exploratory study (2018-2021).

b) Chief guide for Postgraduate Medical Students DM Thesis-         Three (Completed), One (Ongoing)  

i) Effect of Cannabis on serum Brain-Derived Neurotrophic Factor level and its relation with psychosis – A cross-sectional exploratory study (2017- 2020).

ii) Clinical and Biochemical Assessment of Compliance to Disulfiram and Abstinence for Alcohol: A Longitudinal Study in Alcohol Dependent Subjects (2019-Ongoing).  

iii) Association of Phosphatidylethanol (PEth) Levels with Severity of Alcohol Dependence in Treatment-Seeking Primary Alcohol Users (2020- Ongoing).

c.Co-guide for Postgraduate Medical Students M.D. Thesis- Seventeen (Completed), Five (Ongoing)  

i)   Suppression of Acute effects Morphine Following Administration of Buprenorphine (1991-1993).  

ii)   Assessment of Abuse Liability of Buprenorphine, Among Detoxified Heroin Dependent Subjects (1992-1994).  

iii)   Abuse Liability of Nitrazepam Among Detoxified Opioid Addict Population (1994-1996).  

iv)  Effect of Buprenorphine on Psychomotor Performance in Buprenorphine Maintained Subjects (2001- 2003).  

v)   Study of Drug Abuse Among Alleged Offenders Brought to Forensic Medicine for Medical Examinations Under the Custody of South-Delhi Police (2001- 2003).  

vi)  Comparison of Efficacy of Tramadol and Buprenorphine in Detoxification of Opioid Dependent Patients (2004-2006).  

vii)  Attenuation of Acute Effects of Morphine at Different Doses of Sublingual Buprenorphine (2005-2008). 

viii)  A study on the Effects of nicotine on the Cognitive Function in Subjects with Schizophrenia (2007-2010).  

ix)   Effect of Intravenous Buprenorphine on Psychomotor and Cognitive Functioning in Opioid Dependent Patients Receiving Oral Dextropropoxyphene (2007-2010).  

x)   Effect of intravenous naloxone in opioid-dependent men on sublingual buprenorphine maintenance treatment (2012-2014).  

xi)   Cue Induced Craving In Adolescent Inhalant Users: A Functional Magnetic Resonance Imaging (fMRI) Study ( 2012-2015).  

xii)  Effectiveness of Smoking cessation intervention in opioid-dependent subjects on agonist maintenance treatment (2014-2016).  

xiii)  FMRI changes associated with Cue-induced craving in tobacco smokers (2015-2017)  

xiv)  Oral methadone versus sublingual buprenorphine for treatment of acute opioid withdrawal: a randomized, double-blind, double-dummy, controlled study (2015-2017).  

xv)  Association between Serum C-reactive Protein Level and Alcohol consumption Among Patients of Alcohol Use Disorders: A Cross-sectional, Exploratory Study (2016- 2019).  

xvi)  Preliminary assessment of the therapeutic efficacy of intermittent theta- burst magnetic stimulation (iTBS) in treatment resistant depression: A double-blind sham-controlled study (2018-2021).  

xvii) A Study of Serum Brain-Derived Neurotrophic Factor levels in Patients of Schizophrenia on Clozapine therapy and its Association with Clinical Profile (2018- 2021).  

xviii) Brain Derived Neurotrophic Factor gene polymorphism (Val66Met) association with plasma BDNF levels and clinical variables in Major Depressive Disorder patients (2019-Ongoing).  

xix) Assessment of clinical and neuroendocrine response to induced stress in detoxified opioid dependent subjects (2019-Ongoing).  

xx) Assessment of treatment response, inflammatory cytokine and mit-DNA 10398A/G polymorphism in Familial Bipolar Disorder(BD) (2019-Ongoing).  

xxi) Assessing the Long-term Effects of Lithium Maintenance Therapy on Cognition in Patients with Bipolar Disorder (2020- Ongoing).  

xxii) Assessment of Thyroid echogenicity, volume and functioning in chronic lithium users (2020- Ongoing).

d.        Co-guide for Postgraduate Medical Students DM Thesis-          Four (Completed), One(Ongoing)  

i)    Study of sleep parameters in Opioid parameters in Opioid Dependent Patients maintained on Buprenorphine (2016- 2018).

ii)    An exploratory study to assess the association between Nicotine Metabolite Ratio (NMR) and Smokeless Tobacco Use parameters (2016- 2019).  

iii)    Effect of combined administration of injection buprenorphine and different doses of naloxone in opioid-dependent men maintained on sublingual buprenorphine (2016-2019).  

iv)    A randomized single-blind sham-controlled trial to evaluate the effect of Transcranial direct current stimulation(tDCS) on craving among smokers (2018- 2020).  

v)    Feasibility of Out-patient based Buprenorphine assisted Opioid withdrawal management: An Observational Study Comparing Men and Women (2020- Ongoing).

e.    Chief guide for Ph.D. Student Thesis- Three (Completed)

i)    Effect of nalbuphine on opiate withdrawal in rats: Behavioural, Biochemical and Molecular study ( completed).  

ii)    Assessment of Biochemical Measures in Adolescent Inhalant users (completed).

iii)    A comparative study of Ethyl glucuronide (EtG) and Fatty acid ethyl ester (FAEE) with other conventional biomarkers in Alcohol Dependent subjects (2016-2021)

f.   Co-guide for Ph.D Student Thesis- Two

i)    Study on the association of polymorphism, Methylation and Expression status of monoamine pathway genes with Alcohol Dependence (ongoing)

ii)   Psychological aspects and family factors among adolescents with substance use disorders: a descriptive study of users and non-users. (completed)

9.    Number of Research Projects  

    a.    Funded Research Projects:

            Chief Investigator:

1. R. Jain., D. Mohan. Role of Dopamine in Experimentally Induced Nicotine Tolerant Rats (Council of Scientific and Industrial Research, Govt. Of India, funded, 1997-2001 completed).
2. R. Jain., R. Ray. Blocking of Enhanced Sensitivity to Behavioral Effects of Naloxone Induced by Narcotic Agonists in Rats (All India Institute of Medical Sciences, funded 1999- 2000, completed).
3. R. Jain., D. Mohan. Role of Nitric Oxide Synthase Inhibitors In Modifying Nicotine Withdrawals in Rats (Council of Scientific and Industrial Research, Govt. Of India, funded 2001- 2005, completed).
4. R. Jain. Effects of the NMDA Receptor Antagonist (Ketamine) to the Operant Decrement Produced by Naloxone in Morphine-treated Rats. (All India Institute of Medical Sciences, funded 2002- 2003, completed).
5. R. Jain., S. Jhanjee., V. Jain. R. Schnoll. Efficacy of Varenicline for Smokeless Tobacco Use in India (Indo US Collaborative Project funded by National Institute on Drug Abuse (NIDA), R21 DA026404, NIH, US Govt. USA. in collaboration with AIIMS and UPENN (University of Pennsylvania) 2011- 2014,completed). Funds: Rs. 69,00,000
6. R. Jain., A. Ambekar, R. Quraishi “Feasibility of transporting urine samples of drug users on filter paper for screening drugs of abuse: A pilot exploratory study” ( Indian Council of Medical Research funded, 2012- 2014, completed). Funds: Rs. 12,26,000
7. R. Jain., T.S. Roy, A. Dhawan. “Effect of nalbuphine on opiate withdrawal in rats: Behavioural, Biochemical and Molecular study ( Indian Council of Medical Research funded, 2012- 2015,completed). Funds: Rs. 46,02,228.
8. R. Jain., S. Jhanjee, A. Jabeen, “Role of Delphinium denudatum (Jadwar) in a Rat Model of Nicotine Dependence” (funded by Ministry of AYUSH, 2017- 2020, completed Rs. 29.16 lakhs).

Co-Investigator:

1. D. Mohan., R. Jain., H. Pal. Health Status of Workers with Chronic Opioid Exposure at Govt. Opium and Alkaloid Factory, Ghazipur, U.P., (Ministry of Finance, Govt. of India, funded 1998-2001, completed).

2. D. Mohan., R. Jain., H. Pal. Identification and Management of Alcohol Use Related Disorders in Districts Hospital in Goa. ( WHO India , Ministry of Health, Govt. of India, funded, 2002- completed).

3. A. Dhawan., R. Jain., A. Chopra. To test the Effectiveness of Oral Substitution with Buprenorphine and to establish a protocol developed for oral substitution with Buprenorphine. ( UNODC funded, 2005-2010).

4. S. Jhanjee, R. Jain., H. Sethi. Oral Substitution Treatment in Tihar Prisons. Funded by UNODC-ROSA, (October. 2008-2012, completed).

5. A. Dhawan. R. Jain., D. Yadav. Effectiveness of Yoga in patients of Opiate Dependence. AYUSH, MOH & FW (2009-2011, completed).

6. A. Dhawan. R. Ray., R. Jain., A. Ambekar., D. Yadav. A. Chopra. Methadone Maintenance Treatment in India: A feasibility and effectiveness study. ( UNODC funded, 2011-2014, completed)

7. A. Ambekar, R. Ray., R. Jain, A. Dhawan, A. Chopra, H. Sethi. Post Marketing Surveillance of Methadone (funded by M/s Rusan Pharmaceuticals, 2012 - 2014, completed) Fund: Rs. 13,70,250.

8. Y.P.S. Balhara., R. Jain. A comparative study of prevalence of metabolic syndrome among patients with Opioid and Alcohol Dependence Syndrome. (funded by AIIMS, New Delhi, 2013 –completed).

9. G. Shankar, S. Jhanjee., R. Jain., P. Dayal, A. K. Mishra. Cognitive Behavioural based Intervention in Group Setting for Tobacco Cessation in tertiary de- addiction centre in Northern India Approved (funded by ICMR, ongoing, 2015-2016, Funds: 4,37,280/-).

10. 10. R. D. Pattanayak, S.K. Khandelwal., R. Jain. Response to Lithium prophylaxis among patients with Bipolar Disorder: Relationship with clinical variables and inflammatory cytokine (TNF-α). (funded by AIIMS, 2015- 2017, completed, Funds: Rs 1,80,000).

11. S. Sarkar., R. Jain. Serum BDNF levels in patients with opioid dependence during the early withdrawal period: A case control study. (funded by AIIMS, 2015- 2017, Funds: Rs 3,15,000).

12. R. Quraishi., R.Jain., A. Ambekar., R. Rao. Feasibility of transporting blood/ serum samples on to filter paper to screen for biomarkers of harmful alcohol use among opioid dependent patients on agonist maintenance treatment: a pilot study in community setting. (funded by AIIMS, 2016- ongoing, Funds: Rs 2,80,000/).

13. S. Sarkar, A. Sharma., R. Jain, Y.P.S. Balhara. Relationship of serotonin pathway polymorphisms with self harm behaviour among patients with opioid dependence. (funded by Science and Engineering Research Board,   Division of Science and Technology, Govt. of India 2016 -Completed).

14. R. Bhad., R. Jain., A. Dhawan., R. Rao. Comparative assessment of stress and coping among adolescent with recent inhalant abuse: A case control study (Funded by AIIMS,2018- Completed).

15. R. Quraishi., R. Rao, A. Ambekar., R. Jain. Dopamine gene polymorphism and disulfiram treatment response in relation to compliance and side/adverse effect in ADS patients. (Funded by AIIMS, 2018- Completed).

16. B. Chatterjee., R. Jain., A. Dhawan. Comparison of serum Corticotrophin Releasing Factor (CRP) levels in detoxified opioid-dependent subjects with healthy controls. (Funded by AIIMS, 2018-Completed).

17. R. Pattanayak., K. Senthil, R. Jain., R. Quraishi. Biomarkers of Lithium Response in Bipolar disorder: assessment of the clinical markers, peripheral blood-based markers and structural neuroimaging markers (pertaining to gray matter volume) in individuals with bipolar disorder on long-term lithium prophylaxis (funded by Science and Engineering Research Board, Division of Science and Technology, Govt. of India, 2018- Ongoing).

18. R.K. Chadda, R. Jain., R. Lal., R. Rao., R. Quraishi. “Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India: A Multi-centric Study. (Funded by Deptt of Revenue, Ministry of Finance, Govt of India, 2017-ongoing).  

  19.   R. Quraishi., A. Ambekar., R.   Jain.   An   evaluation   of mu-opioid receptor gene polymorphism (A118G) and long term naltrexone treatment response in North Indian alcohol-dependent patients. (Funded by

          ICMR,     Govt. of India, 2019 - ongoing).

  20.   P. Mandal., R. Jain. Role of significant other involvement in retention and outcome on naltrexone among opioid-dependent individuals: An open-label comparative study (Funded by AIIMS, 2020- Ongoing).

b) Non Funded Departmental Supported Research Projects:

Chief investigator:

Heroin Dependent Subjects (1992-1993, completed).

1. R. Jain, N. G. Desai, H. P. Jhingan, M. Vaswani, B. M. Tripathi. Self Validation of Opiate use in Opiate Addicts. (1993-1994, completed).

2. R. Jain, A. Dhawan. Concordance between Self-reported Drug Use and Urinalysis in Opioid Dependent Subject on Maintenance in the Community (1999-2000, completed).

3. R. Jain. A comparative Evaluation of Efficacy of Diazepam and Buprenorphine In Suppression of Opioid Withdrawal Signs in the Rats (1999- 2000, completed).

4. R. Jain. Influence of Sweet Tasting Solutions in Morphine Withdrawal - A pilot study ( 2003, completed).

5. R. Jain Role of Sweet tasting Solutions in modifying the Opioid Withdrawals in rats (2004, completed).

6. R. Jain. Effect of Nitric Oxide Synthase Inhibitor to the Operant Decrement Produced by Naloxone In morphine Treated Rats (2004-2006).

7. R Jain., Effect of Nitric Oxide Synthase Inhibitor 7-NI on Sensitization to the Operant Decrement Produced by Naloxone in Morphine Treated Rats. (2006- 2008).

8. R. Jain, Jhanjee, S. Balhara, YPS, Sethi H. Validity of self-reported tobacco use among opioid dependent subjects (2007-completed).

9. R. Jain, Sethi H.   Evaluation of   Abuse of   Prescription    Drugs Among Opioid Dependent Patients Based On Urinalysis ( NDDTC funded, AIIMS, 2007-completed).

10. R. Jain, Balhara, YPS, Evaluation of illicit drug use in the opioid dependent subjects maintained on sublingual buprenorphine: Role of urine screening (2007-completed).

11. R. Jain, Balhara YPS, Shamsunder S, Sagar R. Screening of tobacco use among psychiatric disorders: A pilot study based on urinalysis and self-report ( 2008-completed).

12. R Jain., Effect of Nitric Oxide Synthase Inhibitor L-NNA on Sensitization to the Operant Decrement Produced by Naloxone in Morphine Treated Rats. (2009- 2012).

13. R. Jain, Compliance of Prescribed Benzodiazepines in Alcohol and Opioid Dependent Subjects Based on Urinalysis. (2010-completed). 

14. R. Jain, R, Sagar, Raman Deep Pattanayak. Validity of self-reported tobacco use among patients with bipolar disorder visiting the psychiatric OPD (2010-completed).  

15. R.Jain, R. Quraishi, P. Majumdar. Comparison of self-report and biological measures for alcohol, tobacco and illicit drugs in alcohol dependent patients (2010-completed).

16. Jain, R., Balhara YPS, Quraishi, R. Assessment of biochemical and haematological profile of opioid dependent patients receiving Buprenorphine/Buprenorphine –naloxone combination (2012-ongoing).

17. Jain, R., Balhara YPS, Quraishi, R. Evaluation of compliance in patients receiving naltrexone for long term management of opioid dependence (2012- completed).

18. R.Jain,   Quraishi, R. Estimation of nicotine in urine samples spotted on filter paper in substance users (2013-completed).

19. R.Jain. An efficient screening method for simultaneous detection of cotinine, pentazocine and pheniramine in urine of substance users by Gas Chromatography- Nitrogen- Phosphorus Detector (2015- completed).

20. R.Jain., Jhanjee S., Quraishi, R. Effect of smoking on Platelets Monoamine Oxidase B activity levels in Opioid Dependent Patients on Maintenance Treatment: An Exploratory study. (2016-completed). 

  21.  R. Jain., Sarkar,S. Urinalysis based evaluation of compliance and pattern of drug use among opioid dependent subjects prescribed tramadol at a tertiary care treatment Centre (2016-completed).

  22.  R. Jain. Sood, M., Verma, R., Sarkar,S. BDNF levels in patients of First Episode Schizophrenia: A Pilot Study (2017-Completed).

  23. R. Jain. A Retrospective study of concurrent Non-Prescribed Medicinal and Illicit Drug Use by Opioid Dependent Patients Prescribed with Buprenorphine (2018-Completed).

  24. R. Jain. Assessment of Cannabis use among Alcohol and opioid Dependent Subjects based On urinalysis. A Retrospective Chart Review (2019- Completed).

  25  R. Jain. Chatterjee, B. Laboratory Assessment of Codeine Abuse among Substance-abuse patients based on urinalysis (2020- Completed).

  26. R. Jain. Pattanayak, R., Pattern and trends of serum lithium levels in consecutive samples received at lithium laboratory between Jan 2015-March 2020: a retrospective review (audit) of laboratory records(2020- Completed).

  27. R. Jain. Pattanayak, R., Chadda, R.K.Profile of substance use based on urine drug analysis for consecutive referrals from psychiatric services: a retrospective review of laboratory records between 2015-2020(2020- Completed).

  28. Jain, R., Chatterjee, B. Detection of Naltrexone in urine by LC-QTOF-Mass Spectrometry and its application to Naltrexone compliance in substance users (2021-Completed).

Co-Investigator

1. H. Pal, R. Jain, Investigation and Management of Psychotropic Substance Problems in Primary Care settings, Phase I, Pilot study (Assist, WHO, 1998, completed).
2. A. Dhawan, R. Jain. Concordance between Self-Reported Drug Use and Urinalysis in Out patient Opioid Dependence subjects (1998-1999, completed).
3. S. Malhotra ., R. Jain. Current Pattern of Naltrexone Maintenance and Patient Compliance (2003 -2004 completed).
4. Raman Deep Pattanayak , R, Sagar, R. Jain. Assessment of knowledge, attitude and perceived health risk for tobacco among patients with bipolar disorder (2010- completed).
5. R Quraishi, R. Jain Association of ANKK I polymorphism and Nicotine Dependence (ND): A Pilot Study (2012- completed).
6. Balhara YPS., Jain, R., A urinalysis based evaluation of cannabis use among opioid dependent subjects maintained on buprenorphine: A retrospective study (2012-completed).
7. Quraishi R. Jain R, Ambekar A. Comparative evaluation based on clinical and laboratory profile of HIV screened positive and negative treatment seekers from a tertiary care treatment centre: a retrospective chart analysis study. (2014-2015).
8. R. Quraishi, A. Ambekar, R. Jain., P. Dayal., A. Aggarwal.To explore and compare the association of various demographic, clinical and laboratory factors with Delirium Tremens (DT) among patients with Alcohol Dependence (AD), admitted with and without a diagnosis of DT, based upon review of clinical records (2017-Completed).

10.       Honours and Academic Achievements:  

U.P. Board National Merit Scholarship (June 1972-June 1974).  

Was awarded Junior Research Fellowship, Council of Scientific and Industrial Research. Government of India, from Jan’79 to June’81 and Senior Research Fellowship, Council of Scientific and Industrial Research, Government of India, from June, 1981 to June, 1983 for carrying out, Ph.D. work in Natural Product Chemistry at Indian Grassland and Fodder Research Institute Jhansi, Indian Council of Agricultural Research, Government of India, affiliated to Bundelkhand University.  

Was awarded Post Doctoral Fellowship, Council of Scientific and Industrial Research, Government of India, from November, 1983 to November, 1984 and Ministry of Health, Government of India, from December, 1984 to June, 1986 for carrying out Post Doctoral research work in the area of Bio-organic synthetic chemistry (i.e. Synthesis of antiestrogens, bioassays and receptor binding studies) at Central Drug Research Institute, Lucknow, Council of Scientific and Industrial Research, Government of India, India.  

In 1990, was nominated by Government of India, under United Nations Fund for Drug Abuse Control Programme and was sent for five months advance training in ‘Analytical’ Methods of Body Fluid Analysis from September, 1990 to January, 1991 at Institute of Legal Medicine, Forensic Toxicology Laboratory University of Padova, Italy. During this period, was awarded United Nations Fellowship.  

Inclusion of Biographical Note in the proposed volume of “Reference Asia”. ‘Indo- European who’s and who FI publication, New Delhi, India, (1995).

Member of Committee constituted by the Govt. of India, Ministry of health & FW, to suggest the norms to strengthen the De-addiction Centres of the country (1995).  

Assistant Editor: Medico-legal update, since 1995  

Project Reviewer: Department of Science & Technology, Govt. of India, New Delhi, since 1996.  

Was Recipient of National Institute on Drug Abuse NIDA INVEST FELLOWSHIP, US Govt. for the year 1996-1997 to carry out Research Project entitled Role of Dopaminergic system in Caffeine Tolerance under Prof,. S.G. Holtzman at Deptt. of Pharmacology, School of Medicine, Atlanta, Georgia 30322-3090 for a period of 13 months.

Edited a Manual for Laboratory personnel for upcoming De-Addiction Centres of the country. Also contributed a chapter in this manual.  

Was nominated as examiner of associateship in Information Science (IAS) to evaluate the dissertation for two years CSIR Masters Degree level Course, Govt. of India (since 1999).  

Was elected as a Fellow of Royal Society of Chemistry, U.K and was awarded FRSC, 2000.  

Was Recipient of NIDA International Travel Award for presenting papers in 4th NIDA / INVEST Meeting on Building International Research on Drug Abuse, Continuing Focus on Children and Youth, Acapulco, Mexico (June, 11-12th, 1999). & in College on Problems of Drug Dependence, 61st Annual Scientific Meeting, Acapulco, Mexico, (June 12 th – 17th, 1999).  

Was Recipient of NIDA International Travel Award for presenting papers in 6th NIDA / INVEST Meeting on Building International Research on Drug Abuse: Children and Youth at Risk at Scottsdale, Arizona, USA (June, 14- 16th, 2001) & in College on Problems of Drug Dependence, 63rd Annual Scientific Meeting, Scottsdale, Arizona, USA (June 16 th –21th,2001).  

Was Recipient of Travel award to attend NIH Stigma and Global Health Conference at Bethesda, Maryland, USA (Sept. 5 th -7 th, 2001).  

Was Recipient of Society for Research & Tobacco (SRNT) Global Network Travel award to participate and present paper in the annual meeting at Savannah, Georgia, USA, dated (February 20 th – 23rd, 2002).  

Was Recipient of NIDA International Travel award for   participating and presenting papers in 7th NIDA INVEST meeting on Building International Research on Drug Abuse: Treatment Innovations, at Quebec City (Canada, June 13-15th, 2002) & in College on Problems of Drug Dependence, 64thrd Annual Scientific Meeting, at Quebec City (Canada, June 8th - 13th, 2002).  

Was Recipient of NIDA International Travel award for participating and presenting paper in 8th NIDA INVEST meeting on Building International Research on Drug Abuse: Emerging Trends and Patterns in Drug Abuse (Miami , June 13-19th, 2003) & in College on Problems of Drug

Dependence, 65thrd Annual Scientific Meeting, at Miami Florida (Miami, Florida , June 13 th - 19th, 2003).  

Was Recipient of Society for Research & Tobacco (SRNT) Global Travel award to participate and present paper in the Fifth European Conference of the Society for Research on Nicotine and Tobacco at Padova , Italy , (Nov.20 th – 22rd, 2003).  

National Institute of Drug Abuse (NIDA) International   Travel award for participating and presenting paper in 9th Satellite meeting of 2004 NIDA International Forum: Progress through Collaboration in conjunction with 66-th Annual Scientific meeting of College on Problem of Drug Dependence (CPDD) (June11 th -17 th, 2004), San Juan, Puerto Rico , USA.  

Chaired the session "Glutamate -What's all the Excitement?” session in College on Problems of Drug Dependence, (CPDD), USA meeting on 15th June (11.20Am-12.35PM). San Juan, Puerto Rico , USA, 2004 . This is a highly esteemed meeting in the field of Drug Dependence.  

Examiner MSc Toxicology Ist year, Lab II, Jamia Hamdard, Hamdard University, 2004  

Examiner Diploma in Pharmacy (Biochemistry Practical exam), Delhi Institute of Pharmaceutical Sciences & Research, Govt. of Delhi, 2004.  

Appointed as steering committee member of International Drugs of Abuse Research Society (IDARS) in Oct, 2004.  

Was Recipient of WHO/NIDA/CPDD International traveling Fellowship award for participating and presenting paper in Satellite meeting of 2005 NIDA International Forum: Linking Drug Abuse and HIV/AIDS in conjuction with 67-th Annual Scientific meeting of College on Problem of Drug Dependence (CPDD) (June17th-23rd, 2005), Orlando, Florida, USA.  

Appointed as expert for convening of Selection Committee meeting for filling the post of Research Officer   (Biochemistry) and ARO (Biochemistry) , CCRAS , Deptt. of AYUSH , MOH & FW, Govt. of India, Sept. 2005  

Was Rapporteur for the session Nutrition and Co-infections . In Indo-US Partnership Workshop on “Drug Abuse and HIV/AIDS in Northeast Region of India” , (Oct. 27-29th , 2005), New Delhi, India.

 Was Recipient of Distinguished International Scientist Collaboration Award (DISCA), National Institute on Drug abuse, US, Govt. USA for the year 2006 to carry out Research Project entitled “Interactions between modafinil and cocaine in the mesolimbic dopamine (DA) system of rats” with Dr. Michael Baumann, Staff Scientist , IRP, NIDA, NIH, DHHS, at 5500 Nathan Shock Drive, John Hopkins Bayview Campus, Baltimore, MD, 22124, USA for a period of three months (1/6/06-31/8/06).  

Was Recipient of NIDA International Travel Award for presenting papers in 6th NIDA / INVEST Meeting on International Trends and Needs in Drug Abuse Research at Scottsdale, Arizona, USA (June, 16th -19th, 2006) & in College on Problems of Drug Dependence, 67th Annual Scientific Meeting, Scottsdale, Arizona, USA (June 18th –22nd, 2006).

Appointed as member of the selection committee for the convening of Departmental Promotion Committee meeting for filling the post of Assistant Director (Biochemistry), CCRAS, Deptt. of AYUSH, MOH & FW, Govt. of India, April, 2006  

Was Recipient of NIDA ISAM ( International Society of Addiction Medicine) Travel Award for presenting paper in 10th Annual Scientific Meeting of ISAM at Cape Town, South Africa (Nov. 17th-20th, 2008).

 Nominated by MOH & FW, GOI to participate in “14th World Conference on Tobacco or Health’ scheduled on 8-12th March 2009 at Mumbai and also honoured to chair the Session entitled “ Health Effects, Screening and Biomarkers”.

 Examiner Delhi University for evaluation of Ph. D thesis in “Biomedical Sciences’, since 2009.  

Was nominated as a member of Technical Advisory Committee for Tobacco testing Labs in India, by Directorate General Health Services, MOH Nirman Bhawan, New Delhi.” (since 2009).  

Project Reviewer: Council of Scientific & Industrial Research, (CSIR), Human resource development group, Extramural research Division, Govt. of India, New Delhi, since  2010.  

Project Reviewer: Indian Council of Medical Research (ICMR) Govt. of India ,New Delhi, since 2010.  

Was Recipient of NIDA International Travel ward for participating and presenting paper in “2010 NIDA International forum: Drug Abuse Research Policy and the Public Good & attending CPDD 72th Annual Scientific Meeting, at the Fairmont Scottsdale, Scottsdale, Arizona, USA (11th -17th June, 2010).  

Appointed as Delhi University Ph.D viva Examiner in ‘BioMedical Sciences’ in the year 2012.  

Delivered a Invited talk on "Role of Laboratory Services in Drug Dependence Treatment Programme" on Forensic Science day, Amity University Noida (23rd March, 2012).  

Member of the Selection   Committee in the interview board, July 2012 session for admission to Msc- Ph.D combined Degree Program in Biomedical Sciences, Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, Delhi.  

Was Recipient of NIDA International Travel award for participating and presenting paper in 2013 NIDA International forum: Building International Collaborative Research on Drug Abuse and attending CPDD 75th Annual Scientific Meeting, at The Hilton Bayfront Hotel, San Diego, CA, USA. (14th - 20th June, 2013).

Was one of the judges for the poster Session” Drugs and Toxicology” 11th Indo Pacific Association of Law, Medicine and Science Congress 2013 (INPALM 2013), at Shangri-La Hotel, Malaysia, Kuala Lumpur (5th- 10th Oct. 2013).  

Was one of the experts on Substance abuse and a potential member in WHO meeting of the guidelines development group for the World Health Organization "Guidelines on the management of opioid overdose" held at WHO headquarters in Geneva, Switzerland ( 19th- 20th Feb. 2014).  

Was Recipient of NIDA International Travel award for participating and presenting paper In 2015 NIDA International forum: Building International Collaborative Research on Drug Abuse at Arizona Biltmore Hotel, Phoenix, Arizona, USA.  (12th - 15th June 2015).

Has been honored with a Certificate of appreciation as “Pioneer” in recognition of two decades of Building International Collaborative research on drug abuse on the 20th – Anniversary of NIDA International forum in the 2015 NIDA International Forum meeting held at Arizona Biltmore Hotel, Phoenix, Arizona, USA.  (12th - 15th June 2015).  

Appointed as a member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation): World Health Organization, Geneva, August 2015- Nov.2019.  

Has been honored with “Fellow” in “Forensic Toxicology” during IAMLE (Indian Association of Medico-legal Experts ) 2016 meeting held in Hyderabad 29th-31st Jan. 2016.  

Convener and Chaired the Symposium entitled “Role of non-nicotinic Acetylcholine receptors in nicotine dependence: Implications for smoking cessation treatment” In, XXXIV Annual Meeting of Indian Academy of Neurosciences, National Brain Research Centre, Manesar, Gurgaon Dist. Haryana (Oct.19th -21st 2016).  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation) attended and participated in the Thirty-eight meeting of the Expert Committee on Drug Dependence (ECDD) held in Geneva, Switzerland, 14th – 18th November 2016.  

Organizing Secretary of “First National Conference on Addiction Psychiatry” Organised by National drug Dependence Treatment Centre and Department of Psychiatry, AIIMS, New Delhi (Nov. 27th- 29th, 2017). The theme of the conference was “Emerging Trends in Addiction Psychiatry”. Four hundred delegates from various parts of the country registered for this conference making it a truly national event.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the 2nd Working Group of the Expert Committee on Drug Dependence (ECDD)WHO Headquarters Geneva, Switzerland, 8th -10th May 2017.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the World Health Organization (WHO) “Thirty-ninth Expert

Committee Meeting on Drug Dependence (39th ECDD, 6-10th Nov.2017, WHO Headquarters, Geneva, Switzerland.  

Appointed as Examiner for evaluation of Ph.D. thesis in Forensic Science as well as Ph.D. Viva-Voce Examiner, Department of Forensic Science, Punjabi University in the year 2017.  

As a Co-PI, framed a proposal entitled “Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India: A Multi- centric Study” in association with Centre Chief and NDDTC faculty colleagues which got approved by the Deptt of Revenue, Ministry of Finance, Govt of India. A sum of Rs. 6,50,62,928 was sanctioned to NDDTC in the financial year 2016-17 for carrying out this activity at the Centre ( 2017-2022). This is the first study in the country for establishing detection methods for Newer Psychoactive Substances (NPS) in the biological specimens (urine) among Substance Abuse treatment seekers.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the World Health Organization (WHO) “40th Expert Committee Meeting on Drug Dependence (40th ECDD, 4-8th June 2018, WHO Headquarters, Geneva, Switzerland.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the 5th WHO/UNODC Expert Consultation on New Psychoactive Substances on 24th -25th September 2018 followed on 26 and 27 September by a Working Group to prepare the forthcoming 41st ECDD, WHO Headquarters, Geneva, Switzerland.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the World Health Organization (WHO) “41st Expert Committee Meeting on Drug Dependence (41st ECDD, 12th-16th Nov. 2018, WHO Headquarters, Geneva, Switzerland.  

Appointed as external Expert for the selection of faculty position at National Institute of Mental Health and Neurosciences (NIMHANS), MOH& FW, Govt. of India (Feb. 2019).  

Appointed as a Steering Committee member of the Guru Gobind Singh Indraprastha University, Govt. of Delhi (July 2019).  

Special Invitee for Center research and Consultancy (CRC) Committee meeting Guru Gobind Singh Indraprastha University, Govt. of Delhi (July 2019).  

Co-Chair of the Local Organising Committee of International Society of Addiction Medicine (ISAM 2019) New Delhi (Nov. 13th-16th, 2019).  

Re-appointed as a member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation): World Health Organization, Geneva, Nov. 2019-2023.

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the virtual online 8th Working Group of the Expert Committee on Drug Dependence (ECDD) held on 20.4.2020 and 8.5.2020.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation, attended and participated in the World Health Organization (WHO) Virtual Online “43nd Expert Committee Meeting on Drug Dependence (43rd ECDD, 12th-20th Oct. 2020).  

As an expert participated in a webinar on the topic 'Evidence Multistat'- A fully automated analyzer to detect New Psychoactive substances and Roadside drug testing dated 7.6.2020 organized by the University of Calicut, Malappuram, Kerala in collaboration with Kerala Police Academy and Indian Criminology & Forensic Science Association (ICFSA).  

Appointed as a Steering Committee member of the Guru Gobind Singh Indraprastha University, Govt. of Delhi, attended and participated in Steering Committee meeting (online) held on 22.10.2020.  

Admission Committee Member (external) for admission to Ph.D. Program at Center of Excellence in Pharmaceutical Sciences (CEPS), for the session 2020-2021 & 2021-2021, Guru Gobind Singh Indraprastha University, Govt. of Delhi, Sector 16-C Dwarka Delhi.  

Nominated as a member for the Centre Research and Consultancy Committee(CRC) for “Centre of Excellence in Pharmaceutical Sciences (CEPS)” for the years 2020-2021 & 2021-2022, Guru Gobind Singh Indraprastha University, Govt. of Delhi, Sector 16-C Dwarka Delhi.  

As an expert attended and participated in a Virtual meeting of the Scientific support Group for hand holding in analysis and conducting research for National Tobacco Testing Laboratories (NDDTL) on 6.10.2020, organized by MoH & FW. GOI.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation), attended and participated in the virtual online 44th ECDD -9th Working Group of the Expert Committee on Drug Dependence (ECDD) held on 19th May 2021.  

As an Expert Committee member of the WHO Expert Advisory Panel on Drug Dependence (Dependence Liability Evaluation, attended and participated in the World Health Organization (WHO) Virtual Online “44th Expert Committee Meeting on Drug Dependence (44th ECDD, 12h-17th Oct. 2021).  

Appointed as International Committee Member of College on Problems of Drug Dependence (CPDD), June 2021 for three years.  

Chaired a number of sessions in national and international meetings.

11.  Membership of Scientific Societies

National:  

1. Indian Pharmacological Society.
2. Indian Society for Mass Spectrometry.
3. Indian Association for Medico-Legal Experts.
4. Indian Academy of Neuroscience
5. Fellow of the Indian Association for Social Psychiatry
6. Society for promotion of Research and Education in   Mental Health and Substance Use

International  

1. Member of Indo Pacific Association of  Law, Medicine and Sciences
2. Associate member of College on Problems of Drug    Dependence, USA
3. International    Brain   Research   Organization (IBRO) France
4. Fellow of Royal Society of Chemistry, U.K.
5. Society for Research on Nicotine and Tobacco Int. USA
6. International    Drug Abuse Research Society (IDARS), USA

12.    Reviewer for Scientific Peer-Reviewed Journals

1. Indian Journal of Pharmacology
2. Indian Journal of Medical Research
3. Brain Research Bulletin
4. Neuroscience letters
5. Nicotine & Tobacco Research
6. The National Medical Journal of India
7. Asian Journal of Psychiatry
8. Journal of Psychoactive drugs
9. Drug Development Research

13.     List of Publication & Papers Presented: In National and International Conferences.  

Peer-reviewed National & International Journals till date: 146Nos. Chapter in Books/report/Manual/monograph till date: 22 Nos.  

A.      PUBLICATION  

List of papers published 

A)    Journals year 2010 Onwards:

1. Jain, R., Balhara, Y.P.S.   Impact of alcohol and substance abuse on adolescent brain: a preclinical perspective. Ind. J. Physiol. Pharmacol. 54: 213-234 (2010).

2. Pattanayak, R.D., Jain, R., Ray, R. Jain, R., Validity of self-reported benzodiazepine use among consecutive treatment seekers at a tertiary care drug dependence centre. Ind. J. Physiol. Pharmacol. . 54: 337-343 (2010).

3. Balhara,Y.P.S., Jain , R. Dhawan, A., Mehta, M. Assessment of Abuse Liability of Pheniramine     among     Opioid     Dependent     Human     Subjects.           JSU (doi/pdf/10.3109/14659891.2010.513753). 7 Dec 2010. 

4. Jain, K.D., Jain, R., Dhawan, and A. Double-Blind, Double-Dummy Randomized Controlled Study of Memantine versus Buprenorphine in Naloxone Precipitated Acute Withdrawal in Heroin Addicts. J Opioid Manag 7:11-20 (2011). 

5.  Jain, R., Pattanayak, and R.D. Pattern of consecutive urinalysis results for patients on take-home buprenorphine-naloxone in India: Do patients really take it at home? JSU, 17: 230-234 (doi:10.3109/14659891.2011.555055) (2012).

6.   Jain, R., Pattanayak, and R.D. Pattern of consecutive urinalysis results for opioid- dependent patients on dextropropoxyphene: Do patients comply? Addict Disord. Their Treatment. 10: 180-190 doi: 10.1097/ADT.0b013e3182133b76. March 30, 2011.  

7.  Balhara,Y.P.S., Jain , R. Sundar, S., Sagar,R. A comparative study of reliability of self-report of tobacco use among patients with bipolar and somatoform disorder. J Pharmacol Pharmacother. 2: 174-178, IP: 122.161.215.210...doi: 10.4103/0976- 500X.83282, PMID: 21897711, (2011.)  

8.  Quraishi, R., Jain, R., Pattanayak, R.D. Laboratory Profile of Current Injecting Drug Users Seeking Treatment at a Tertiary Care Center in India: What do the Regular Blood Tests and HIV Screening Say? Addict Disord. Their Treatment doi: 10.1097/ADT.0b013e3182404043. , 2011.

9.  Pattanayak, R.D. Sagar, R., Jain, R. Perceived health risks, attitudes, and readiness to quit tobacco among Bipolar disorder patients in regular contact with mental health services: An exploratory study from India. J Ment Health. 21: 83-90, (2012).  

10.  Srinivas, T.R, Jain R., Tripathi B.M., Pal, H.P., Balhara, Y.P.S. Extent of use and concordance of self-report and urinalysis of benzodiazepine abuse: a comparative analysis in alcohol and opioid-dependent individuals. Addict Disord. Their Treatment 11: 26-35 (2011).

11.  Jain, R., Balhara, Y.P.S., Jhanjee, S., Sethi, H. Concordance between urinary cotinine levels and self-reported tobacco use among drug dependents: a pilot study. Subs Abuse 33: 99-102, doi:10.1080/08897077.2011.630947 (2012).

12.  Balhara, Y.P.S., Jain, R. Urinalysis based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects. J Opioid Manag. 8: 45-49 (2012).

13.  Pattanayak, R.D. , Jain, R., Sagar, R. Reliability of self-reported tobacco use in bipolar disorder: An exploratory study of euthymic patients visiting a tertiary care hospital in India. IJPM.43: 153-63 (2012).

14. Jain, R., Quraishi, R., Majumder, P., Pattanayak, R.D. Comparison of self- report and biological measures for alcohol, tobacco, and illicit drug use in consecutive alcohol-dependent patients visiting a tertiary care centre. JSU., April 19, 1-9 , (doi:10.3109/14659891.2012.674625) (2012).

15. Balhara, Y.P.S., Jain, R. A urinalysis-based comparative study of compliance on Buprenorphine and Buprenorphine/Naloxone combination used as Opioid Substitution Therapy. Journal of Innovations in Clinical Neurosciences, 9: 24-29 (2012.

16. Pattanayak RD, Sagar R, Jain R. Perceived health risks, attitude and readiness to quit tobacco among euthymic bipolar disorder patients in regular contact with mental health services: An exploratory study from India. J Ment Health, 21: 83-90 (2012).
17. Balhara, Y.P.S., Jain, R., Rajesh Sagar, A Shyam Sundar. Use of cotinine urinalysis to verify self reported tobacco use among male psychiatric out- patients. Lung India , 29: 217- 220 (2012).
18. Balhara, Y.P.S., Jain, R. A Receiver Operated Curve (ROC) based evaluation of change in sensitivity and specificity of cotinine urinalysis for detecting active tobacco use. J Cancer Res Ther.;9: 84-89 (2013) doi: 10.4103/0973- 1482.110384.
19. Balhara, Y.P.S. Jain, R. A urinalysis based study of buprenorphine and non- prescription opioid use among patients on buprenorphine maintenance. J. Pharmacol.Pharmacother. 3: 15–19. doi: 10.4103/0976-500X.92496. (2012).IP: 122.151.134.137. (2012).
20. Jain, R. Ensuring balance in national policies on controlled substances: Guidance for availability and accessibility of controlled medicines (Book Review, WHO, Geneva, 2011). Indian J Med Res 136:314-316 (2012).
21. Quraishi, R., Jain, R., Anish, P.K. Naltrexone level and biochemical profile of opiate-dependent patients on naltrexone maintenance programme: A pilot study. Addict Disord. Their Treatment 12 (4):231-235, December 2013. (2013)
22. Chawla, J.M., Pal, H., Lal, R., Jain, R., Schooler N. Comparison of efficacy between Buprenorphine and Tramadol in the detoxification of opioid (heroin) dependent subjects. J Opioid Manag. 9: 43-50 (2013).
23. Quraishi R, Jain R., Ambekar, A . The use of dried blood spot samples in screening drugs of abuse.  Pharmacology & Pharmacy 4: 152-159 (2013).
24. Quraishi, R., Pattanayak, R.D., Jain, R., Dhawan A. A descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care centre in India. Indian J Psychol Med 35: 174-179 (2013). doi: 10.4103/0253-7176.116249.
25. Jain R. Jhanjee, S., Jain, V., Gupta, T., Mittal, S., Goelz, P., Wiley, P., Schnoll,   R.A. A Double-Blind Placebo-Controlled Randomized Trial of Varenicline for Smokeless Tobacco Dependence in India. Nicotine Tob. Res. 16: 50-57 (2014) doi: 10.1093/ntr/ntt115.
26. Quraishi, R., Jain R., Chatterjee, B. Laboratory profile of cannabis dependent and concurrent other substance users seeking treatment at a tertiary care centre in India. Int J High Risk Behav Addict 2: 107-11,(2013) doi: 10.5812/ijhrba.10993.
27. Jain R., Gupta, T., Majumder, P. Pharmacological intervention of Nicotine dependence. Biomed Res Int. 2013;2013:278392. doi: 10.1155/2013/278392. Epub 2013 Dec 29.PMID:24490153
28. Quraishi, R., Jain, R. ANKK1/TaqA1 Genotyping from Dried Blood stored on Filter Paper Among Alcohol & Nicotine Dependent Subjects. British Biomedical Bulletin 2: 263-266 (2014).
29. Jain, R. Book Review entitled “WHO Expert Committee on Drug Dependence, Thirty-fifth Report” WHO, Geneva, 2012. Indian J Med Res. 139: 789-791. (2014).
30. Balhara, Y.P.S., Jain, R. Cannabis use among opioid-dependent individuals on opioid substitution. J. Pharmacol.Pharmacother. 5: 203-205 (2014).
31. Jain, R., Raghav, R., Roy, T.S., Dhawan, A. Kumar, P. Attenuation of opiate withdrawals by Co-administration of Nalbuphine in Opiate Dependent Rats. Alcohol and Alcoholism, 49: Suppl, 1, 148 (2014).
32. Jhanjee, S., Dayal., P., Shankar, R., Jain, R. Opportunities and challenges for youth Tobacco Cessation. Indian J Soc. Psychiatry, 30: A10 (2014).
33. Chatterjee, B., Quraishi, R., Jain, R. Socio-demographic and drug use characteristics of treatment-seeking cannabis users at a tertiary care centre in India. Addict Disord. Their Treatment 13: 110-115 (2014)doi: 10.1097/ADT.0b013e31828bf7f2.
34. Bhad, R., Mehta, M., Dhawan, A., Jain, R. Neurocognitive assessment of adolescent inhalant users in treatment setting of India. Indian J Psychiatry 56: SupplS1: 19-62. (2014).
35. Jain, R., Raghav, R., Roy, T.S., Dhawan, A. Kumar ,P. Attenuation of opiate withdrawals by Co-administration of nalbuphine in opiate-dependent rats. Alcohol and Alcoholism, 49: Suppl.1, i48 (2014).
36. Jhanjee, S., Pant, S., Girdhar,R., Gunasekhar,R., Jain, R., Sethi, H. In-Prison outcomes of buprenorphine maintenance for prisoners: Results from a pilot intervention in Tihar prisons, India. Alcohol and Alcoholism, 49: Suppl.1, i64. (2014).
37. Jhanjee, S., Dayal., P., Shankar, R., Jain, R. Opportunities and challenges for youth Tobacco Cessation. Indian J Soc. Psychiatry, 30: A10 (2014).
38. Bhad R., Jain, R., Dhawan, A., Mehta, M. Biochemical Assessment of Inhalant Use among Adolescents: A Pilot Study from Tertiary De-Addiction Center of India. J Subst Abuse Alcohol 2: 1021-1024 (2014).
39. Jain R. An efficient screening method for detection of toluene-based inhalant abuse in urine by Gas Chromatography-Nitrogen Phosphorous Detector. Addict Disord. Their Treatment 14: 47-52 (2015) doi: 10.1097/ADT.0b013e31829bb3d0
40. Jhanjee, S., Suruchi, P., Girdhar, N., Sethi, H., Gunasekaran, Rengaswamy., Jain, R., Sarangi, J. Opioid Substitution Treatment in Tihar prisons, India: Process of implementation. Int J Drug Policy. 26:890-1(2015) doi: 10.1016/j.drugpo.2015.05.016. Epub 2015 PMID:26123894. 
41. Dhawan A., Chopra, A., Jain, R., Yadav, D., Vedamurthachar. Effectiveness of yogic breathing intervention on quality of life of opioid dependent users. Int J Yoga. 8:144-147 (2015). doi: 10.4103/0973-6131.154075. PMID:26170596
42. Jain, R., Jhanjee, S., Jain, V., Gupta, T., Mittal, S., Chauhan, P., Raghav, R., Goelz, P., Schnoll, R.A. Biochemical Validation of Self-Reported Smokeless Tobacco abstinence among Smokeless Tobacco Users: Results from A Clinical Trial of  Varenicline in India. J Psychoactive Drugs. 47:331-335(2015) doi: 10.1080/02791072.2015.1073412. PMID:26317285
43. Jhanjee, S. Jain, R., Jain, V., Gupta, T., Mittal, S., Goelz, P., Schnoll, R. Evaluating craving withdrawal and affect as correlates of cessation in a randomized double-blind placebo-controlled clinical trial of Varenicline for smokeless tobacco dependence in India. J Psychoactive Drugs 47: 325-3309(2015) doi: 10.1080/02791072.2015.1075092. PMID:26317176
44. Mandal, P., Jain, R., Jhanjee, S. Psychological barriers to tobacco cessation in Indian buprenorphine-naloxone maintained patients -A pilot study. Indian J Psychol Med. 37:299-304 (2015) doi: 10.4103/0253-7176.162944. PMID: 26664077. 
45. Jain, R., Verma, A. Laboratory approach for diagnosis of toluene-based inhalant abuse in a clinical setting. J Pharm Bioallied Sci. 8:18-22 (2016) doi: 10.4103/0975-7406.164293.
46. Bhad, R., Jain, R., Dhawan, A., Mehta, M. Why do young people sniff? An exploratory study of adolescent inhalant abuse from north India . J Subst Use 2016, 00(00): 1–3 . DOI: 10.3109/14659891.2015.1082158.
47. Verma, A., Jain R., Dhawan., A, Lakshmy, R. Assessment of Lipid Peroxidation Biomarker Malondi-aldehyde Among Adolescent Inhalant Users. Ind. J. Pharmacol. 2015 :| 47; S145.
48. Raghav, R., Jain, R., Roy, T.S., Dhawan, A., Kumar, P. Effect of Acute and Chronic Administration of Nalbuphine on Motor Activity in Opiate Dependent. Ind.  J. Pharmacol. 2015; 47:| S66.
49. Das, M., Jain, R., Dhawan, A., Kaur A. Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial. J Opioid Manag. 12:421-430 (2016) doi: 10.5055/jom.2016.0361.
50. Quraishi, R., Jain, R., Ambekar A. Hematological profile of alcohol-dependent subjects Report from a tertiary care treatment centre in India. Int J Pharma Res Health Sci. 2016; 4: 1420-1423.
51. Qureshi,   R.,   Jain,   R.,   Ambekar,   A.,   Mishra,   A.K.   Association   of ANKK I polymorphism with co-morbid alcohol and nicotine dependence: A pilot study from a tertiary care treatment center in North India. Indian J Med Res. 145:33-38 (2017) doi: 10.4103/ijmr.IJMR_458_14.

     

52. Jain, R., Quraishi, R., Verma, A. Evaluation of Dried Urine Spot Method to Screen Cotinine among Tobacco Dependents: An Exploratory study. Indian J Psychol Med. 39 : 469-474 (2017).
53. Jain, S., Dhawan, A., Kumaran, S.S., Pattanayak, R.D., Jain R. cue-induced craving among inhalant users: Development and preliminary validation of a visual cue paradigm. Asian J Psychiatr. 30:202-207, (2017)doi: 10.1016/j.ajp.2017.10.004. PMID: 29126097
54. Jain, R., Quraishi, R., Verma, A. Gupta, P. "Dried Urine Spots for Detection of Benzodiazepines. Ind. J. Pharmacol. Indian J Pharmacol. 49:465-469 (2017). doi: 10.4103/ijp.IJP_578_16.
55. Verma, A., Jain, R., Dhawan, A., Lakshmy, R. Evaluation of oxidative stress and toluene exposure among adolescent inhalant users at a tertiary care centre of North India. Free Radical Biology and Medicine. 112(Supplement 1): 37, 2017.
56. Singh R, Grover T, Gupta R, Ambekar A, Jain R and Sharma A. “An Association Study of the COMT and GABA Gene Variants with Alcohol Dependence.” J Addict Res Ther (2017), 8:6DOI: 10.4172/2155-6105.1000350
57. Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Psychiatry. 2018; 60 ( S-1):43.
58. Jhanjee S., Jain R., Jain V., Gupta T., Varshney M., Schnoll R. Understanding the correlates of successful abstinence in a randomized double-blind placebo-controlled trial of varenicline for smokeless tobacco dependence in India. Tobacco Induced Diseases. 2018; 16(1): A350.
59. Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Psychiatry. 2018; 60 ( S-1):43.
60. Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian J Psychol Med 2017;39 (4) 386.
61. Verma A, Jain R, Dhawan A, Lakshmy R. Socio-demographic and Biochemical Profile of Adolescent Inhalant Users Seeking Treatment at a Tertiary Care Centre of India Indian J Psychol Med 2017;39 (4) 459-460.
62. Quraishi R, Jain R, Bera SC, Ambekar A. Association of Alcohol Use Pattern with Liver Enzyme Levels: Report from a Tertiary Care Treatment centre in India Indian J Psychol Med 2017;39 (4) 458.
63. Thapaliya S, Jain R, Ambekar A, Mishra A, Yadav D.Effectiveness of brief intervention for moderate/High Risk Alcohol Use Among Opioid Dependent Patients on Buprenorphine Maintenance Indian J Psychol Med 2017;39 (4) 457.
64. Singh Balhara YP, Jain R, Kuppili PP, Shukla A, Chawla N, Gupta R. Which Criteria to Use to Identify Metabolic Syndrome among Patients with Addictive Disorders?: Observations among Patients with Alcohol and Opioid Dependence Syndrome.Indian J Endocrinol Metab.22:565-568 (2018)doi: 10.4103/ijem.IJEM_617_17. 
65. Sarkar S, Jain R, Kethawath SM, Gupta R, Kumar M. Serum BDNF levels in patients with opioid dependence during the early withdrawal period: A case-control study. Neurosci Lett. 681:100-104 (2018). doi: 10.1016/j.neulet.2018.05.048.
66. Raghav R, Jain R, Dhawan A, Roy TS, Kumar P. Chronic co-administration of nalbuphine attenuates the development of opioid dependence. Pharmacol Biochem Behav. 175:130-138. (2018) doi: 10.1016/j.pbb.2018.10.001.
67. Jain R, Ghosh S. A Retrospective Study of Concurrent Non-Prescribed Medicinal and Illicit Drug Use by Opioid Dependent Patients Prescribed with Buprenorphine. Addc Drug Abuse J 2018, 1: 000108.
68. Jain, R., Quraishi, R ., Verma, V., Ambekar, A. Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users Indian J Pharmacol. 2019 ; 51: 40–44. doi: 10.4103/ijp.IJP_305_18 PMCID: PMC6444835
69. Quraishi, R., Varshney, M., Singh, A., Singh, D., Kumar, M., Rao, R., Jain,      R., Ambekar.A.   Use of Filter Paper to Measure Alcohol Biomarkers among Opioid- Dependent Patients on Agonist Maintenance Treatment: A Community -Based Study.  Indian     J   Psychol Med. 2019          Nov-Dec; 41:   529–534. doi: 10.4103/IJPSYM.IJPSYM_304_19 PMCID: PMC6875832
70. Jain, R. Critical Issues in Alcohol and Drugs of Abuse Testing. Indian. J. Med. Res. Indian J Med Res 2019;150:646-647
71. Ghosh, S., Jain R., Jhanjee, S., Rao, R., Mishra, A.K. Alcohol biomarkers and their relevance in detection of alcohol consumption in clinical settings. Int Arch Subst Abuse Rehabil. 2019; 1(1), 1–8.
72. Kethawath, S.M., Jain. R., Dhawan, A., Sarkar, S. A review of peripheral brain- derived neurotrophic factor levels in alcohol-dependent patients: Current understanding. Indian J Psychiatr. 2020; 62: 15-20. IP: 183.83.37.156.
73. Tripathi, R., Dhawan, A., Rao., R, Mishra, A.K, Jain, R., Sinha, S. Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine.. J Addict Med. 2020 Mar/Apr;14(2):132-138. doi: 10.1097/ADM.0000000000000539.PMID: 30964756
74. Tripathi R, Rao R, Dhawan A, Jain R, Sinha S Opioids and sleep - a review of literature. Sleep Med. 2020 Mar;67:269-275.doi: 10.1016/j.sleep.2019.06.012. Epub 2019 Jul 3.PMID: 32081638
75. Kethawath,S.M., Jain R., Dhawan, A., Sarkar, S. Trajectory of liver function tests during the initial alcohol detoxification period: A preliminary analysis. Indian J Psychiatr. 2020; 62: 225-226.

76. Jain, R., Verma, A. Laboratory Profile of Women Substance Users Seeking Treatment at Tertiary Care Centre in North India: A Retrospective Study. J Addict Res. 2020;4: 6-8.

77. Dhagudu, N.K., Ambekar, A., Agrawal, A., Rao, R., Mishra, A.K., Jain, R., Singh S. Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double-blind, within-subject, crossover study among opioid-dependent subjects. .Drug Alcohol Rev. 2020 Jul;39(5):595-603. doi: 10.1111/dar.13057. Epub 2020 Mar 11.PMID: 32162420   

78. Ghosh, S., Jain, R., Rao, R., Jhanjee, S., & Mishra A K (2020) Can Ethyl Glucuronide in Hair Be Associated with Alcohol Use in Heavy Drinkers? [Abstract no.1248]. In: Proceedings of the 59th Annual Meeting of the Society of Toxicology and Tox-Expo; 2020 March 16-19; Anaheim California, USA: The Toxicologist- Supplement to Toxicological Sciences, 174(1) 60.

79. Kethawath, S.M., Jain. R., Dhawan, A., Sarkar, S. An Observational Study of Serum Brain-Derived Neurotrophic Factor Levels in Patients with Alcohol Dependence during Withdrawal. J Psychoactive Drugs. . 2020 Aug 4:1-7. doi: 10.1080/02791072.2020.1795327.PMID: 32748710.

80. Jain, S., Dhawan, A., Kumaran, S.S., Deep, R., Jain, R. BOLD activation during cue-induced craving in adolescent inhalant users. Asian J Psychiatr. 2020 Apr 21;52:102097.   doi:   10.1016/j.ajp.2020.102097.   Online   ahead    of print.PMID: 32454423 

81. Singh J, Verma R, Raghav R, Sarkar S, Sood M, Jain R. Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study, Asian J Psychiatr. 2020 Dec;54:102370. doi: 10.1016/j.ajp.2020.102370. Epub 2020 Aug 29.PMID: 33271690.

82. Goyal, ShriGopal., Ambekar, A., Jain R., Mehta, M., Mishra, A. Intravenous Buprenorphine does not impair psychomotor and cognitive functioning in Opioid ependent patients using oral Dextropropoxyphene: A randomized, double- blind, ross-over study. Journal of Mental Health and Human Behaviour, 2020, 25: 45- 2.

83. Jain, R., George, A.B., Narnoli, S. Haematological Changes in Alcohol and Substance Use Disorders- An Overview, Int Arch Subst Abuse Rehabil 2020, 2: 2-6, DOI: 10.23937/2690-263X/1710006.

• 84. Jain R, Ghosh S. Assessment of Cannabis use among alcohol and opioid- dependent subjects based on urinalysis-A retrospective review. Asian J Psychiatr. 2020 Oct;53:102388. doi: 10.1016/j.ajp.2020.102388. Epub 2020 Aug 27.PMID: 32911458   

  85. Ghosh S, Jain R,   Singh S, Rao R, Mishra AK, Jhanjee S. A simplified approach for determination of urinary ethyl glucuronide by gas chromatography-mass spectrometry. Anal        Sci        Technol         2021; 12:35;         1-9.       https://doi.org/10.1186/s40543-021-00290-6

  86. Quraishi R, Sarkar S, Jain R. Impact of Chronic Alcohol and Opioid Dependence on Biochemical Parameters: A Retrospective Case-Control Study from a Tertiary Care Treatment Center in North India. Addict Health 2021; 13(3): 148-55.

  87. Raghav R, Jain R, Jacob TG, Dhawan A, Roy TS. Co-administration of nalbuphine attenuates the morphine-induced anxiety and dopaminergic alterations in morphine-withdrawn rats. Psychopharmacology 2021;238(4):1193-1211. doi: 10.1007/s00213-021-05765-3.

  88  Quraishi R, Sharma J, Jain R, Ambekar A. Influence of catechol-O-methyltransferase enzyme gene polymorphism on alcohol and tobacco consumption in North Indian treatment seeking population. Indian J Psychiatry,202163: (3), 240-244. 10.4103/psychiatry.IndianJPsychiatry_465_20

  89. Jain R , Siddiqui M.Z., Waseem M., Raghav R., Jabin A., Jhanjee, S. Therapeutic Usefulness of Delphinium denudatum (Jadwar): An Update. International Journal of Herbal Medicine 2021; 9(4): 97-100

    90. Jain R, Chatterjee B, Gupta A. Assessment of codeine abuse among substance- abuse patients based on urinalysis: A retrospective study. Asian J Psychiatr. 2021; 62:102719.  

    91. Jain R, Mishra S, Agrawal A, Chadda RK. An improved method for detection of urinary diethylamine to monitor disulfiram compliance in alcohol-dependent subjects. Asian J Psychiatr. 2021; 64:102756.  

    92. Sarkar S, Singh R, Sharma A, Pandit MA, Gupta R, Singhal D, Jain R, Balhara YP. Association of Serotonergic Pathway Gene Polymorphisms With Behavioral Parameters in Patients With Opioid Dependence. Cureus   2021: 13(11): e19310. DOI 10.7759/cureus.19310

    93. Chatterjee B., Jain R., Chawla, N., Raghav R. Serum Corticotrophin Releasing Factor (CRF) and its correlation with stress and craving in detoxified opioid- dependent subjects. Asian J Psychiatr. 2022; 68: 102964   

    94. Jain R , Raghav R., Waseem M., Jabin A., Jhanjee, S. Protective Role of Delphinium denudatum Wall in Nicotine Dependent Rat. Basic Clinical Neuroscience (accepted).  

    95. Jain R., Ghosh R., Saifi N. An efficient method for simultaneous detection of Pheniramine, Pentazocine and cotinine in urine by Gas Chromatography in De- addiction program. Addict Health (accepted).

 B)  Chapter in Books

1. Jain, R. TLC in Clinical Chemistry, In: Practical Thin Layer Chromatography, Sherma, J., Fried, B.(ed). CRC Press, Boca-Raton, FL, Chap. 7, pp 131-152 (1996).

2. Jain, R. Addictive Potential of Cannabis: Pre-clinical Aspects, In: Cannabis-Health Damage? Legislative Options, Mohan, D., Pal, H.R., (eds). Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India, pp 30- 46 (1997).

3. Jain, R., and Sherma, J. Planar Chromatography in Clinical Chemistry In: Encyclopedia of Analytical Chemistry Instrumentation And Applications, Meyer,  R.A. (ed), John Wiley & Sons Ltd, Chichester, pp 1583-1603 (2000). 

4. Ray, R. Jain, R. Mongia, M. and Kumar, R. Substance Abuse in Young People: Biological Considerations. In Mental Disorders in Children and Adolescents: Need and Strategies for Intervention, CBS Publishers, New Delhi, pp 82-87 (2005).

5. Jain, R, Role of Laboratory Services In: Lal R (Ed). Substance Abuse Disorder: Manual for Physicians, National Drug Dependence Treatment Centre, All India, Institute of Medical Sciences, New Delhi, 2005: pp127-137.

6. Jain, R. Role of Laboratory Services in Management of Substance Use Disorder In: Lal R., Gupta S. (Eds). Substance Abuse Disorder: Manual for Nurses, National Drug    Dependence Treatment Centre, All India, Institute of Medical Sciences, New Delhi, 2007: 169-181.

7. Jain, R. Role of Laboratory Services in Management of Substance Use Disorder In: Lal R., Gupta S. (Eds). Substance Abuse Disorder: Manual for Nurses, National Drug Dependence Treatment Centre, All India, Institute of Medical Sciences, New Delhi, 2007: 169-181. (reprinted , 2013) 

8. Jain, R. Role of Laboratory Services In: Lal R (Ed). Substance Abuse Disorder: Manual for Physicians, National Drug Dependence Treatment Centre, All India, Institute of Medical Sciences, New Delhi, 2nd Ed. 2013: pp127-137. (reprinted , 2013) 

9. 9.   Quraishi, R., Jain, R., Ambekar, A. Dried Blood Spots for Testing Drugs, In: Dried Blood Spots for Testing Drugs of Abuse, In: Detection of Drug Misuse : Biomarkers, Analytical Advances and Interpretation , Wolff, K (ed) RSC , UK , 2017 pp.127- 146.

C)  Editor : and Author

1. Jain, R. Analytical Methods, In: Detection of Drugs of Abuse in Body Fluids: A Manual for Laboratory Personnel. Jain, R. (ed)., Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India, pp, 18-44 (1998).
2. Jain, R., and Shantanu De. Buprenorphine – Pharmacology, Pharmacokinetics and Therapeutic Potential. In: Proceedings on National Workshop on Treatment of Opiate Dependence with Special Focus on Maintenance Therapy. Jain, R., and Dhawan, A. (ed.). Drug Dependence   Treatment Centre, All India Institute of Medical Sciences, New Delhi, pp,47-53 (2000).
3. Jain, R., and Mukherjee, K. Biological Theories of Tobacco abuse. In: Proceedings of the workshop on assessment of tobacco as a gateway substance and information available on evidence relating to tobacco, alcohol and other forms of substance abuse (Eds. Dhawan A, Jain, R., Kumar, N.), New Delhi, India: Centre for Behavioral Sciences, AIIMS, sponsored by WHO India, & MOH & FW, GOI, pp. 33-38 (2004).
4. Jain, R. Relevance and Usefulness of Laboratory Service in South Asia, Ray, R. (ed)., In: South Asia Drug Demand Reduction,. Report United Nations International Drug Control Programme, Regional Office of South Asia, New elhi, India, pp, 214-221 (1998).
5. Jhanjee, S., Jain, R., Sethi, H. Rolling out of Opioid Substitution Treatment (OST) in Tihar Prisons, India: Scientific Report, A collaborative project of UNODC- ROSA, AIIMS & Tihar Prisons, Published by United Nations Office on Drugs and Crime, , Regional Office for South Asia,(2013).
6. Dhawan, A., Rao, R., Ambekar, A., Chopra, A., Jain, R., Yadav, D., Ray, R. Methadone Maintenance Treatment in India: A feasibility and effectiveness Report. UNODC (ROSA) and NDDTC (AIIMS), New Delhi, India, Published by United Nations Office on Drugs and Crime, Regional Office for South Asia. (2014).
7. Ambekar, A., Rao,R., Varshney,M., R., Prashanth., Dhawan, A.,   Jain, R., Ray, R., Bhola, s., Gupta, N., Chopra, A., Sethi, H. Post Marketing Surveillance of

D)  Report/Chapter in Report

5.       WHO Expert Committee on Drug Dependence. 37thWorld Health Organ Tech RepSer. 2016;(998):1-34. PMID: 29144065

6.        WHOExpertCommitteeonDrugDependence.38thWorldHealthOrganTechRepSer. 2017;(1005):1-44.

            7.        WHOExpertCommitteeonDrugDependence.39thWorldHealthOrganTechRepSer. 2018;(1009):1-48.

8.        WHO Expert Committee on Drug Dependence.40thWorld Health Organ Tech RepSer. 2018;(1013):1-48.

9.        WHO Expert Committee on Drug Dependence.41stWorld Health Organ Tech RepSer. 2019;(1018):1-57.

          35. Tobacco and Nicotine Related Studies at National Drug Dependence Treatment Centre, AIIMS: An overview. R. Jain., in Fifth European Conference of the Society for Research on Nicotine and Tobacco at Padua, Italy (Nov, 18 th - 24th, 2003).

          36. Influence of Sweet tasting solution in morphine withdrawal - A pilot study R. Jain., K. Mukherjee., in XXXVI Annual Conference of Indian Pharmacological Society, New Delhi ( Dec, 5 th -7th, 2003).

          37.Effect of Nitric Oxide Synthase Inhibitors in Nicotine Precipitated Withdrawal Rats. R. Jain., K. Mukherjee., In World Assembly on Tobacco Counters Health, New Delhi ( March, 7 th -11th, 2004).

          38. Role of sweet tasting solution in opiate withdrawal. R. Jain., K. Mukherjee., In Satellite Meeting of 2004 NIDA international Forum: Progress through Collaboration , San Juan, Puerto Rico (June 11th -14th , 2004).

39. Effects of the NMDA receptor antagonists (Ketamine) to the operant decrement produced by naloxone in morphine - treated rat. R. Jain., In 66th Annual Scientific Meeting of College on Problem of Drug dependence, San Juan, Puerto Rico (June 12th - 17th, 2004).

          40.Effect of nitric oxide synthase inhibitors in nicotine-dependent rats Society for Research on Nicotine and Tobacco’s: R. Jain. In 11th Annual Meeting held jointly with the 7th SRNT European Conference’ (20th -23rd March 2005) at Prague ‘Czech Republic’.  

          41. Drunken Driving. R. Jain (invited talk). In. Workshop on Road Rage: A study of Aggressive behavior and intervention strategies Deptt. of Psychiatry, AIIMS, New Delhi. (May 4th, 2005).

          42. Role of the laboratory in Primary Health Care. R. Jain (invited talk). In. Workshop on Managing Alcohol Abuse in Primary Care Setting: A study of Aggressive behavior and intervention strategies, National Drug Dependence Treatment Centre, AIIMS, New Delhi. (June 17th-18th, 2005).

            43. Comparison of the effects of nitric oxide synthase inhibitors in nicotine-dependent rats. R. Jain, K. Mukherjee, D. Mohan. In Satellite meeting of 2005 NIDA International Forum: Linking Drug Abuse and HIV/AIDS in conjunction with 67-th Annual Scientific Meeting of College on Problem of Drug Dependence (CPDD) (June 17th -23rd, 2005), Orlando, Florida, USA.

            44. Can you Trust Self-reports among Injectable Drug users in a Clinical Setting? Jain, R., Tripathi, B.M., Varghese, S.T., Kumar, N., Kumar. In 6th NIDA / INVEST Meeting on International Trends and Needs in Drug Abuse Research at Scottsdale, Arizona, USA (June, 16th -19th, 2006). Scottsdale, Arizona, USA.

            45. Patterns of Drug Use: Role of Urine Testing. Jain, R. Sethi Hem. In International Symposium on Forensic Science at Amity Institute of Advance Forensic Science Research and Training (1st-4th August. 2007) Noida, UP, India.

            46. Concordance between Urinary cotinine levels and self-reported tobacco use among drug dependents: A Pilot Study. Jain, R., Balhara, Y.P.S., Jhanjee S., Sethi, H.S. In 5th World Assembly on Tobacco Counters Health, New Delhi (Dec.2nd-5th, 2007).

            47. Comparison of Self-Report of Tobacco Use and Urinary Cotinine Levels among Drug Dependents: A Pilot Study. Jain, R., Balhara, Y.P.S., Jhanjee S., Sethi, H.S. In 14th Annual Meeting February of Society for Research on Nicotine and Tobacco at Portland, Oregon, USA (27th Feb - 1st March, 2008).

            48. Role of urine testing in evaluation of illicit drug use and ensuring compliance in opioid-dependent subjects maintained on sublingual buprenorphine substitution therapy. Jain, R., Balhara,, Y.P.S. In 10th Annual Meeting for the International Society of Addiction Medicine, Cape Town, South Africa (16th -20th Nov, 2008).  

            49. Compliance and detection of illicit drug use among opioid-dependent subjects maintained on sublingual buprenorphine substitution therapy. R Jain, R., Balhara, Y.P.S. In International Conference of Translation Pharmacology and 41st Annual Conference of Indian Pharmacological Society, (18th -20th Dec. 2008), AIIMS, New Delhi. .

             50. Role of Nitric Oxide Synthase Inhibitors in Nicotine Dependent Rats. (invited talk) Jain, R., Mukherjee, K., Mohan D. In: National Symposium on Emerging Trends in Nitric Oxide Research, (12th Jan, 2009), Vallabhai Patel Chest Institute, University of Delhi.

            51. Participated in “Regional Advocacy Workshop on “Tobacco Control Law & Measures” scheduled on 16 th -17th Jan 2009 at Chandigarh in collaboration with MoH & FW, GOI.

            52 . Nominated by GOI & MOH & FW to participate in “14th World Conference on Tobacco or Health’ scheduled on 8 th -12th March 2009 at Mumbai.  

            53. Effects of Nitric Oxide Synthase Inhibitor to the Operant Decrement produced by Naloxone in Morphine Dependent Rats. Jain, R., In: 2nd    Annual International Drug Abuse Research Society (IDARS) & International Society for Neurochemistry Satellite Meeting In Association with Korean Society   for Drug Abuse Research (17 th -21st August 2009), Grand Hyatt Hotel, Seoul, S. Korea.  

            54. Tobacco use: Relationship between self-report and urinary cotinine. Jain, R., Balhara, Y.P.S., Jhanjee, S., Sethi, H. In: Silver Jubilee Year Conference of the Indian Association for Social Psychiatry (16th-17th Nov.) 2009 at Lucknow.  

            55. Neurobiological basis of nicotine addiction: An update (invited talk). Jain, R., Chatterjee, B., In: XXVII Annual Conference of Indian Academy of Neurosciences at Jaipur (18 th -20th Dec. 2009).  

            56. Role of nitric oxide synthase inhibitors to the operant decrement produced by naloxone in morphine treated rats. Jain, R., In: “2010 NIDA International forum: Drug Abuse Research Policy and the Public Good & CPDD 72 Annual Scientist Meeting, at The Fairmont Scottsdale, Scottsdale, Arizona, USA (11th -17th June 2010). 

            57. Compliance of Prescribed Benzodiazepines in Alcohol and Opioid Dependent Subjects Based on Urinalysis. Jain, R., In: 10th Indo-Pacific Congress on Legal Medicine and Forensic Science at Amity University, UP (25 th  -30th. Oct. 2010).  

            58. Attended National Conference on ‘Draft National Policy on Narcotic Drugs and Psychotropic Substances’ (1st-2nd Feb 2011), Govt. of India, Ministry of Finance, Department of Revenue, New Delhi.  

            59. Participated in Sensitization cum Refresher Training Workshop on Opioid Substitution Therapy in Tihar Prisons on 18 February 2011, New Delhi, organized by UNODC (ROSA).             

            60. Drug Abuse Testing in Substance Abuse Treatment Program: AIIMS NDDTC Experience. Jain, R., In: “2nd International Conference on Medical Negligence in Medical Practice and on Recent Advances in Forensic Sciences, Medicine Toxicology at Hotel Riveriera De Goa, at Goa ( 20 th -21st Feb., 2011).  

            61. Pattern of urinalysis results for patients prescribed with dextropropoxyphene in opioid dependent subjects: Do patients really comply? Jain, R., Pattanayak, R.D. In “2011 NIDA International forum: Building International Collaborative Research on Drug Abuse and CPDD 73rd Annual Scientific Meeting from June 17th to 23rd, 2011 at The Westin Diplomat Hollywood, Florida, USA (17th - 23rd June., 2011).  

            62. Participated in Refresher Training on Opioid Substitution Treatment in Tihar Prison on 11th Nov. 2011.  

            63. Delivered an invited talk on “Role of Laboratory Services in Substance Abuse Treatment Programme” to training course Participants of CRCL, Govt. of India, New Delhi (15th Nov. 2011)  

            64. Comparison of self-report and biological measures for alcohol, tobacco and illicit drug use in alcohol-dependent patients Jain, R., Quraishi, R., Majumder, P., Pattanayak, R.D. In “3rd International Conference on Legal Medicine, Medical Negligence in Medical Practice and on Current Trends in Forensic Sciences, Medicine Toxicology at  Hotel Ramada  Jaipur (3rd - 5th Feb. 2012).  

            65. Delivered an invited talk on “Role of Laboratory Services in Drug Dependence Treatment Programme” on Forensic Science Day, at Amity University, UP (23rd March 2012).  

            66. Participated and attended the training programme on “Medical Laboratory Quality Management System And Internal Audit as per IS-ISO 15189” conducted by National Institute of Training for Standardization Bureau of Indian Standards at AIIMS, New Delhi (8th -11th August 2012).  

            67. Laboratory detection of toluene-based inhalant abuse in urine. Jain, R., In “4th International Conference on Legal Medicine, Medical Negligence and Litigation in Medical Practice 4th International Conference on Current Trends in Forensic Sciences, Forensic Medicine & Toxicology at Uday Samudra Hotel, Kovalam, Thiruvananthapuram, Kerala.  (25th- 27th Jan. 2013).  

            68. A randomized double-blind placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India. Jain, R., Jhanjee, S., Jain, V., Gupta, T., Mittal, S., Goelz, P., Schnoll, R., In 2013 SRNT (Society for Research on  Nicotine   and   Tobacco)   19th    Annual   International   Meeting,   Westin   Boston Waterfront Hotel Boston, Massachusetts, USA. (13th-16th March 2013).  

            69. Effect of nitric oxide synthase inhibitor, nitro-l-arginine (L-NNA), on sensitization to the operant decrement produced by naloxone in morphine treated rats Jain, R. In 2013 NIDA International forum: Building International Collaborative Research on Drug Abuse and CPDD 75th Annual Scientific Meeting, at The Hilton Bayfront Hotel, San Diego, CA, USA. (14th - 20th June 2013).  

            70. An Efficient Method for Detection of Opiate in Dried Urine Specimens among Opioid Users. Jain, R., Quraishi R, Verma A, Ambekar A. In 11th Indo Pacific Association of Law, Medicine and Science Congress 2013 (INPALMS 2013), at Shangri-La Hotel, Malaysia, Kuala Lumpur (5th–10th Oct 2013).  

            71. Biochemical Validation of Self-reported Smokeless Tobacco Abstinence Among Smokeless Tobacco Users: Results from a Clinical trial of Varenicline in India. Jain, R., Jhanjee, S., Jain, V., Gupta, T., Mittal, S., Goelz, P., Schnoll, R., In 2014 SRNT (Society for Research on Nicotine and Tobacco) 20th Annual Meeting at Sheraton Seattle Hotel Seattle, Washington, USA (Feb 5-8 th 2014).

             72. Evaluating Craving, Withdrawal and effect as Mediators of Tobacco Cessation in a Randomized Double-Blind Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India. Jhanjee, S., Jain, R., Jain, V., Gupta, T., Mittal, S., Goelz, P., Schnoll, R., In 2014 SRNT (Society for Research on Nicotine and Tobacco) 20th Annual Meeting at Sheraton Seattle Hotel Seattle, Washington, USA (Feb 5-8 th 2014).  

            73. Participated and attended Conference on Stress Reduction Skills: Scientific Update Dogra Hall (Auditorium) IIT Delhi, organized by Sri Sri Global Meditating Doctors Association & Department of Psychiatry AIIMS ( August 30th-31st 2014).  

            74. Attenuation of opiate withdrawals by Co-administration of Nalbuphine in Opiate Dependent Rats. Jain, R., Raghav, R., Roy, T.S., Dhawan, A. Kumar,P., In 16th International Society of Addiction Society (ISAM) Annual Meeting at Pacifico Yokohama Conference Center, Yokohama, Japan (Oct. 2nd- 6th2014).     

            75. Role of Biomarkers for Youth tobacco Cessation: Recent advances, Jain, R., In Symposium entitled “Opportunities and challenges for youth Tobacco” Cessation (Jhanjee, S., Dayal., P., Shankar, R., Jain, R), National Conference of Indian Association for Social Psychiatry (NCIASP 2014) at JSS Medical JSS College hospital, JSS University, Mysore  (Nov.21rd -23rd 2014).  

            76. Urinalysis based evaluation of pattern of drug use among substance users seeking treatment at a tertiary care De-addiction Centre of North India. Jain, R. In IAMLE-2015, 6th International Conference on Legal Medicine, Medical Negligence and            Litigation                  in                       Medical      Practice             and 6th International Conference on Current Trends in Forensic Sciences, Forensic Medicine & Toxicology at Hotel Clarks, Khajuraho, Madhya Pradesh ( Feb. 26th – 28th 2015).  

            77. Evaluation of Dried Urine Spot Method for Detection of Cotinine among Tobacco Users. Jain, R., Quraishi, R., Verma, A. In 2015 NIDA International forum: Building International Collaborative Research on Drug Abuse at Arizona Biltmore Hotel, Phoenix, Arizona, USA. (12th - 15th June 2015).

            78. Effect of Nalbuphine on Plasma corticosterone levels and opiate withdrawal Raghav, R., Jain, R., Roy, T.S., Dhawan, A., Kumar, P. In 2015 NIDA International forum: Building International Collaborative Research on Drug Abuse at Arizona Biltmore Hotel, Phoenix, Arizona, USA. (12th - 15th June 2015).

            80. Evaluation of Dried Urine Spot Method for Detection of Benzodiazepines among Substance Users”. Jain, R. , Quraishi, R., Ambekar, A., Verma, A., Gupta, P. In IAMLE-2016, 7th International Conference on Legal Medicine, Medical Negligence        and        Litigation        in        Medical         Practice         and 7th International Conference on Current Trends in Forensic Sciences, Forensic Medicine & Toxicology at The Central Court Hotel, Hyderabad, Telangana (Jan. 29th –31st 2016).   

            81. Stability of substance use in urine spotted on filter paper at various storage conditions over a 12 weeks period. Jain, R., Quraishi, R., Ambekar, A., Verma, A., Gupta, P. In 12th Indo Pacific Association of Law, Medicine and Science INPALMS Congress 2016), at The Stones Hotel, Bali, Indonesia (17th -23rd September 2016).  

            82. Current understanding of the neurobiology of nicotine dependence: the role of NAchRs and dopamine and their treatment implications. In symposium entitled “Role of non-nicotinic Acetylcholine receptors in nicotine dependence: Implications for smoking cessation treatment” (Jain, R., Chatterjee, B., Mandal, P.) XXXIV Annual Meeting of Indian Academy of Neurosciences, National Brain Research Centre, Manesar, Gurgaon Dist. Haryana (Oct.19th -21st 2016).  

            83. Safety of e-cigarettes- evidence from toxicological studies. In symposium entitled “E-Cigarettes Use: Is It An Acceptable Alternative?” (Jhanjee,S., Jain, R., Chatterjee, B., Mandal, P.) 22nd World Congress of Social Psychiatry (WASP2016), The Ashoka, New Delhi (30th Nov.- 4th Dec.2016).  

            84. New Psychoactive Substances: An Emerging Shift in Forensic Practice. Jain, R. In IAMLE 2017, 8 th International Conference on Medical Negligence and Litigation in Medical Practice, 8th International Conference on Recent Advances in Forensic Sciences, Forensic Medicine & Toxicology, Sep 30th -1st October, AGRA, INDIA at Agra, .2017.  

            85. New Psychoactive Substances: Laboratory Assessment. Jain, R. In: National CME on “Emerging Issues in Substance Use Disorders”, being held on 22nd July 2017 at the NAMS Auditorium, NAMS House, Near AIIMS, New Delhi 110029.

            86. An Overview of Drug Abuse Testing and its Relevance to Clinical Practice" (invited talk). Jain, R. In: Global Initiative of Academic Networks (GIAN) Workshop, on “Neuropharmacology of Addiction” at Panjab University, Chandigarh, October 09-13, 2017, Ministry of Human Resource Development ( MHRD) Govt. of India.  

            87. “Lab testing for nicotine-CO monitor and Urine Cassette test” on the Occasion of “ World No Tobacco Day” to the participants of the Symposium, Jain, R. held on 30th May, 2017, AIIMS New Delhi. 

            88. Laboratory Profile of Women Substance Users Seeking Treatment at Tertiary Care Center in North India: A Retrospective Study. Jain, R., Verma, A. In: 19th International Society of Addiction Medicine (ISAM 2017), Abudhabi (26th- 29th October 2017).  

            89. Drug Addiction & Indian Culture: Cultural Causes and Related Issues. Jain, R. In ISAM Busan 2018, 20th International Society of Addiction Medicine Busan, Republic of Korea ( Nov. 3rd -6th, 2018).  

            90. Effect of hydro-alcoholic extract of Delphinium denudatum (Jadwar) on nicotine withdrawal in nicotine-dependent rats. Jain, R., Raghav, R., Waseem, M., Jhanjee, S., Jabeen, A. In SRNT Europe, Oslo (Sept. 12-14, 2019).  

            91. New Psychoactive Substances: Diagnostic issues and challenges in detection. In symposium entitled “Challenges in Alcohol and Substance Use Testing in De- addiction Programs” ( Jain, R., Ghosh,S., Bhad, R., Sharma, P. )ISAM   New Delhi 2019, 21st International Society of Addiction Medicine New Delhi, India ( Nov. 13th -16th, 2019).  

            92. Analytical approaches for testing drugs in substance use disorder: An overview In Workshop entitled “Advances in Analytical Methods for Detection of Alcohol and Substance Use in Biological Matrices” (Jain., R., Quraishi, R.,Mehta Luthra, P., Jaiswal, A.K., Ahi, S.) ISAM New Delhi 2019, 21st International Society of Addiction Medicine New Delhi, India ( Nov. 13th -16th, 2019).  

            93.     Point of Care Devices for Testing Drugs of Abuse in De-addiction Programs: Limitations and Pitfalls, (Jain R. ) In: INPALMS Congress 2019 Dhaka, Bangladesh (Dec. 9^th-13^th 2019).

            94. Compliance and pattern of drug use among opioid-dependent subjects prescribed tramadol at a tertiary care treatment Centre based on Urinalysis   (Jain R., Sarkar, S.,   Ghosh, S., Singh, S) College on Problems of Drug Dependence (CPDD) 2020 Virtual Meeting NIDA International Poster Session (22-24, June 2020). 

            95. Assessment of Codeine Abuse among substance-abuse patients based on Urinalysis (Jain, R., Chatterjee, B., Gupta, A) Ist ISAM Asia Regional Meeting on Addiction Medicine (ISAM-ASIA) and 14th Addiction Science Congress (ASC), Virtual online meeting organized by Cellular and Molecular Research Center, Iran University of Medical Sciences (3-6 Dec. 2020). .

            96.  Invited lecture entitled “New psychoactive substances and their detection” (Jain   R.)     In Virtual workshop on 'Next-Generation Forensics' conducted by the Department of Life Sciences, University of Calicut, Kerala, India in collaboration with the Kerala Police Academy (Virtual online, 25th Jan. 2021).

            97. Effect of Unani formulation Habb-e-Jawahar on mecamylamine precipitated nicotine withdrawal in rats (Jain, R., Raghav, R., Waseem, M., Jhanjee, S., Jabeen, A.) In virtual Society for Research on Nicotine & Tobacco 2424 American Lane, Madison, USA (24th -27th Feb. 2021).  

            98. Monitoring naltrexone compliance in the urine of opioid-dependent subjects: A simple and fast LC-QTOF-Mass method for detection of naltrexone in urine. (Jain R., Mandal, P., Rana, .S) 2021 Virtual NIDA International Forum Poster &       Virtual College on Problems of Drug Dependence (CPDD) Annual Meeting, USA (22th -24th, June 2021).